Pharma Q2 preview: Indian drugmakers eye growth despite US sales pressure, GST rate cuts | Mint - Mint
Pharma Q2 preview: Indian drugmakers eye growth despite US sales pressure, GST rate cuts | Mint Mint
Why this GST update matters
This article highlights a GST-related development that may be relevant for understanding regulatory trends, compliance focus areas, or policy interpretation. Tracking such updates helps readers stay informed about how GST rules and enforcement practices continue to evolve.